CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease

Overview

Journal Dement Geriatr Cogn Dis Extra

Publisher Karger

Specialty Geriatrics

Date 2014 Feb 12

PMID 24516412

Citations 5

Authors

T Paajanen

T Hanninen

A Aitken

M Hallikainen

E Westman

L-O Wahlund

T Sobow

P Mecocci

M Tsolaki

B Vellas

S Muehlboeck

C Spenger

S Lovestone

A Simmons

H Soininen

Affiliations

Soon will be listed here.

Abstract

Background: Sensitive cognitive global scores are beneficial in screening and monitoring for prodromal Alzheimer's disease (AD). Early cortical changes provide a novel opportunity for validating established cognitive total scores against the biological disease markers.

Methods: We examined how two different total scores of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery and the Mini-Mental State Examination (MMSE) are associated with cortical thickness (CTH) in mild cognitive impairment (MCI) and prodromal AD. Cognitive and magnetic resonance imaging (MRI) data of 22 progressive MCI, 78 stable MCI, and 98 control subjects, and MRI data of 103 AD patients of the prospective multicenter study were analyzed.

Results: CERAD total scores correlated with mean CTH more strongly (r = 0.34-0.38, p < 0.001) than did MMSE (r = 0.19, p = 0.01). Of those vertex clusters that showed thinning in progressive MCI, 60-75% related to the CERAD total scores and 3% to the MMSE.

Conclusion: CERAD total scores are sensitive to the CTH signature of prodromal AD, which supports their biological validity in detecting early disease-related cognitive changes.

Citing Articles

3T sodium-MRI as predictor of neurocognition in nondemented older adults: a cross sectional study.

Lui E, Venkatraman V, Finch S, Chua M, Li T, Sutton B Brain Commun. 2024; 6(5):fcae307.

PMID: 39318783 PMC: 11420980. DOI: 10.1093/braincomms/fcae307.

Automated deep learning segmentation of high-resolution 7 Tesla postmortem MRI for quantitative analysis of structure-pathology correlations in neurodegenerative diseases.

Khandelwal P, Duong M, Sadaghiani S, Lim S, Denning A, Chung E Imaging Neurosci (Camb). 2024; 2():1-30.

PMID: 39301426 PMC: 11409836. DOI: 10.1162/imag_a_00171.

Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.

Kwak S, Oh D, Jeon Y, Oh D, Park S, Kim H J Alzheimers Dis. 2021; 85(3):1357-1372.

PMID: 34924390 PMC: 8925128. DOI: 10.3233/JAD-215244.

Introducing the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus) as an assessment tool for subtle cognitive impairments.

Demeyere N, Haupt M, Webb S, Strobel L, Milosevich E, Moore M Sci Rep. 2021; 11(1):8000.

PMID: 33846501 PMC: 8041764. DOI: 10.1038/s41598-021-87287-8.

Risk Factors and Consequences of Cortical Thickness in an Asian Population.

Hilal S, Xin X, Ang S, Tan C, Venketasubramanian N, Niessen W Medicine (Baltimore). 2015; 94(23):e852.

PMID: 26061305 PMC: 4616471. DOI: 10.1097/MD.0000000000000852.

References

Paajanen T, Hanninen T, Tunnard C, Mecocci P, Sobow T, Tsolaki M . CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study. J Alzheimers Dis. 2010; 22(4):1089-97. DOI: 10.3233/JAD-2010-100459. View

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

Singh V, Chertkow H, Lerch J, Evans A, Dorr A, Kabani N . Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain. 2006; 129(Pt 11):2885-93. DOI: 10.1093/brain/awl256. View

Bakkour A, Morris J, Dickerson B . The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology. 2008; 72(12):1048-55. PMC: 2677470. DOI: 10.1212/01.wnl.0000340981.97664.2f. View

Chandler M, Lacritz L, Hynan L, Barnard H, Allen G, Deschner M . A total score for the CERAD neuropsychological battery. Neurology. 2005; 65(1):102-6. DOI: 10.1212/01.wnl.0000167607.63000.38. View

Di Paola M, Macaluso E, Carlesimo G, Tomaiuolo F, Worsley K, Fadda L . Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. J Neurol. 2007; 254(6):774-81. DOI: 10.1007/s00415-006-0435-1. View

Hughes C, Berg L, Danziger W, COBEN L, Martin R . A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-72. DOI: 10.1192/bjp.140.6.566. View

Jack Jr C, Bernstein M, Fox N, Thompson P, Alexander G, Harvey D . The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008; 27(4):685-91. PMC: 2544629. DOI: 10.1002/jmri.21049. View

Seo E, Lee D, Lee J, Choo I, Kim J, Kim S . Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. Am J Geriatr Psychiatry. 2010; 18(9):801-9. DOI: 10.1097/JGP.0b013e3181cab764. View

10.

Fischl B, Dale A . Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000; 97(20):11050-5. PMC: 27146. DOI: 10.1073/pnas.200033797. View

11.

Sotaniemi M, Pulliainen V, Hokkanen L, Pirttila T, Hallikainen I, Soininen H . CERAD-neuropsychological battery in screening mild Alzheimer's disease. Acta Neurol Scand. 2011; 125(1):16-23. DOI: 10.1111/j.1600-0404.2010.01459.x. View

12.

Rossetti H, Cullum C, Hynan L, Lacritz L . The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord. 2010; 24(2):138-42. PMC: 2920638. DOI: 10.1097/WAD.0b013e3181b76415. View

13.

Lee J, Lee K, Lee D, Kim K, Jhoo J, Kim J . Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci. 2002; 57(1):P47-53. DOI: 10.1093/geronb/57.1.p47. View

14.

Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S . Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 2006; 32(1):180-94. DOI: 10.1016/j.neuroimage.2006.02.051. View

15.

Fjell A, Amlien I, Westlye L, Walhovd K . Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 28(3):252-8. DOI: 10.1159/000241878. View

16.

Dickerson B, Bakkour A, Salat D, Feczko E, Pacheco J, Greve D . The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2008; 19(3):497-510. PMC: 2638813. DOI: 10.1093/cercor/bhn113. View

17.

Desikan R, Cabral H, Hess C, Dillon W, Glastonbury C, Weiner M . Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain. 2009; 132(Pt 8):2048-57. PMC: 2714061. DOI: 10.1093/brain/awp123. View

18.

Barth S, Schonknecht P, Pantel J, Schroder J . [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery]. Fortschr Neurol Psychiatr. 2005; 73(10):568-76. DOI: 10.1055/s-2004-830249. View

19.

Morris J, HEYMAN A, Mohs R, Hughes J, van Belle G, Fillenbaum G . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39(9):1159-65. DOI: 10.1212/wnl.39.9.1159. View

20.

Isaacs B, KENNIE A . The Set test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973; 123(575):467-70. DOI: 10.1192/bjp.123.4.467. View